Edition:
United Kingdom

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

15.31USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$15.31
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
151,761
52-wk High
$20.25
52-wk Low
$7.78

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.36 December 13 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 1 1 1
(2) OUTPERFORM 5 5 5 4
(3) HOLD 1 1 1 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.88 2.00 2.00 1.80

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 6 46.95 66.00 28.00 5.00
Quarter Ending Mar-18 3 44.00 54.00 28.00 --
Year Ending Dec-17 7 137.07 156.67 118.67 51.39
Year Ending Dec-18 7 168.14 220.00 122.00 75.33
Earnings (per share)
Quarter Ending Dec-17 7 -0.36 0.00 -0.59 -1.01
Quarter Ending Mar-18 3 -0.28 -0.01 -0.59 --
Year Ending Dec-17 7 -2.51 -2.05 -2.93 -3.31
Year Ending Dec-18 7 -1.60 -0.53 -3.21 -2.90

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 37.05 41.28 4.23 11.43
Quarter Ending Jun-17 26.46 28.52 2.06 7.79
Quarter Ending Mar-17 21.47 20.86 0.60 2.80
Quarter Ending Dec-16 65.00 1.53 63.47 97.64
Quarter Ending Sep-16 1.25 0.00 1.25 100.00
Earnings (per share)
Quarter Ending Sep-17 -0.51 -0.49 0.02 -3.37
Quarter Ending Jun-17 -0.89 -0.53 0.36 -40.32
Quarter Ending Mar-17 -0.39 -1.15 0.76 -194.87
Quarter Ending Dec-16 0.77 -0.99 1.76 229.07
Quarter Ending Sep-16 -1.09 -0.96 0.13 -12.09

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 46.95 46.95 42.70 40.72 5.00
Quarter Ending Mar-18 44.00 44.00 39.00 39.00 --
Year Ending Dec-17 137.07 137.07 132.38 124.62 51.39
Year Ending Dec-18 168.14 168.14 163.28 159.79 75.33
Earnings (per share)
Quarter Ending Dec-17 -0.36 -0.36 -0.46 -0.49 -1.01
Quarter Ending Mar-18 -0.28 -0.28 -0.42 -0.42 --
Year Ending Dec-17 -2.51 -2.51 -2.65 -2.64 -3.31
Year Ending Dec-18 -1.60 -1.60 -1.75 -1.72 -2.90

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 1 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 1 0
Year Ending Dec-18 0 0 1 0
Earnings
Quarter Ending Dec-17 0 0 1 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 1 0
Year Ending Dec-18 0 0 1 0